Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Implications of the COVID-19 pandemic on eliminating trachoma as a public health problem

View ORCID ProfileSeth Blumberg, Anna Borlase, Joaquin M Prada, Anthony W Solomon, Paul Emerson, Pamela J Hooper, Michael S Deiner, Benjamin Amoah, Deirdre Hollingsworth, Travis C Porco, Thomas M Lietman
doi: https://doi.org/10.1101/2020.10.26.20219691
Seth Blumberg
aFrancis I Proctor Foundation, UCSF, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seth Blumberg
Anna Borlase
bUniversity of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joaquin M Prada
cFaculty of Health and Medical Sciences, University of Surrey, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony W Solomon
dDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Emerson
eInternational Trachoma Initiative, The Task Force for Global Health, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamela J Hooper
eInternational Trachoma Initiative, The Task Force for Global Health, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael S Deiner
aFrancis I Proctor Foundation, UCSF, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Amoah
fLancaster Medical School, Lancaster University, Bailrigg, Lancaster, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deirdre Hollingsworth
bUniversity of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Travis C Porco
aFrancis I Proctor Foundation, UCSF, USA
gDepartment of Epidemiology and Biostatistics, UCSF, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas M Lietman
aFrancis I Proctor Foundation, UCSF, USA
gDepartment of Epidemiology and Biostatistics, UCSF, USA
hInstitute for Global Health Sciences, UCSF, USA
iDepartment of Ophthalmology, UCSF, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Tom.Lietman@ucsf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Progress towards elimination of trachoma as a public health problem has been substantial, but the COVID-19 pandemic has disrupted community-based control efforts.

Methods We use a susceptible-infected model to estimate the impact of delayed distribution of azithromycin treatment on the prevalence of active trachoma.

Results We identify three distinct scenarios for geographic districts depending on whether the basic reproduction number and the treatment-associated reproduction number are above or below a value of one. We find that when the basic reproduction number is below one, no significant delays in disease control will be caused. However, when the basic reproduction number is above one, significant delays can occur. In most districts a year of COVID-related delay can be mitigated by a single extra round of mass drug administration. However, supercritical districts require a new paradigm of infection control because the current strategies will not eliminate disease.

Conclusion If the pandemic can motivate judicious, community-specific implementation of control strategies, global elimination of trachoma as a public health problem could be accelerated.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

All authors gratefully acknowledge funding of the NTD Modelling Consortium by the Bill and Melinda Gates Foundation [OPP1184344]. SB and TML acknowledge NIH R01 EY025350.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No unpublished data was collected or used for this study. Thus IRB approval was not needed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

This is a modeling paper that does not present new data. All methods and parameter values are described within the paper. All code is available at: https://github.com/sblumberg/trachoma---COVID_impact

https://github.com/sblumberg/trachoma---COVID_impact

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Implications of the COVID-19 pandemic on eliminating trachoma as a public health problem
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Implications of the COVID-19 pandemic on eliminating trachoma as a public health problem
Seth Blumberg, Anna Borlase, Joaquin M Prada, Anthony W Solomon, Paul Emerson, Pamela J Hooper, Michael S Deiner, Benjamin Amoah, Deirdre Hollingsworth, Travis C Porco, Thomas M Lietman
medRxiv 2020.10.26.20219691; doi: https://doi.org/10.1101/2020.10.26.20219691
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Implications of the COVID-19 pandemic on eliminating trachoma as a public health problem
Seth Blumberg, Anna Borlase, Joaquin M Prada, Anthony W Solomon, Paul Emerson, Pamela J Hooper, Michael S Deiner, Benjamin Amoah, Deirdre Hollingsworth, Travis C Porco, Thomas M Lietman
medRxiv 2020.10.26.20219691; doi: https://doi.org/10.1101/2020.10.26.20219691

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9772)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1561)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4661)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)